vs

Side-by-side financial comparison of CHIMERA INVESTMENT CORP (CIM) and Inogen Inc (INGN). Click either name above to swap in a different company.

Inogen Inc is the larger business by last-quarter revenue ($68.6M vs $66.2M, roughly 1.0× CHIMERA INVESTMENT CORP). On growth, Inogen Inc posted the faster year-over-year revenue change (3.4% vs 0.5%). Over the past eight quarters, Inogen Inc's revenue compounded faster (4.2% CAGR vs 0.8%).

Chimera Investment Corp is a US-based real estate investment trust (REIT) primarily investing in residential mortgage-backed securities, residential and commercial mortgage loans, and other real estate-related financial assets. It delivers sustainable risk-adjusted returns for shareholders via regular dividend distributions from its investment portfolio.

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

CIM vs INGN — Head-to-Head

Bigger by revenue
INGN
INGN
1.0× larger
INGN
$68.6M
$66.2M
CIM
Growing faster (revenue YoY)
INGN
INGN
+2.9% gap
INGN
3.4%
0.5%
CIM
Faster 2-yr revenue CAGR
INGN
INGN
Annualised
INGN
4.2%
0.8%
CIM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CIM
CIM
INGN
INGN
Revenue
$66.2M
$68.6M
Net Profit
$28.3M
Gross Margin
51.4%
Operating Margin
42.6%
-13.6%
Net Margin
42.8%
Revenue YoY
0.5%
3.4%
Net Profit YoY
119.3%
EPS (diluted)
$0.05
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CIM
CIM
INGN
INGN
Q4 25
$66.2M
$68.6M
Q3 25
$65.0M
$79.1M
Q2 25
$66.0M
$79.2M
Q1 25
$69.2M
$68.5M
Q4 24
$65.8M
$66.3M
Q3 24
$66.5M
$74.9M
Q2 24
$67.3M
$74.4M
Q1 24
$65.1M
$63.1M
Net Profit
CIM
CIM
INGN
INGN
Q4 25
$28.3M
Q3 25
$-580.0K
$-5.3M
Q2 25
$35.5M
$-4.2M
Q1 25
$167.3M
$-6.2M
Q4 24
$-146.5M
Q3 24
$136.5M
$-6.0M
Q2 24
$56.7M
$-5.6M
Q1 24
$129.5M
$-14.6M
Gross Margin
CIM
CIM
INGN
INGN
Q4 25
51.4%
Q3 25
52.2%
Q2 25
52.2%
Q1 25
53.1%
Q4 24
54.7%
Q3 24
55.2%
Q2 24
57.4%
Q1 24
54.5%
Operating Margin
CIM
CIM
INGN
INGN
Q4 25
42.6%
-13.6%
Q3 25
-0.5%
-9.0%
Q2 25
54.3%
-7.7%
Q1 25
-11.2%
Q4 24
-222.6%
-17.2%
Q3 24
-10.4%
Q2 24
84.2%
-9.5%
Q1 24
-25.8%
Net Margin
CIM
CIM
INGN
INGN
Q4 25
42.8%
Q3 25
-0.9%
-6.7%
Q2 25
53.7%
-5.2%
Q1 25
241.7%
-9.0%
Q4 24
-222.6%
Q3 24
205.4%
-8.0%
Q2 24
84.2%
-7.5%
Q1 24
198.8%
-23.1%
EPS (diluted)
CIM
CIM
INGN
INGN
Q4 25
$0.05
$-0.26
Q3 25
$-0.27
$-0.20
Q2 25
$0.17
$-0.15
Q1 25
$1.77
$-0.25
Q4 24
$-2.06
$-0.41
Q3 24
$1.39
$-0.25
Q2 24
$0.41
$-0.24
Q1 24
$1.36
$-0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CIM
CIM
INGN
INGN
Cash + ST InvestmentsLiquidity on hand
$278.6M
$103.7M
Total DebtLower is stronger
$251.5M
Stockholders' EquityBook value
$2.6B
$192.2M
Total Assets
$15.8B
$298.6M
Debt / EquityLower = less leverage
0.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CIM
CIM
INGN
INGN
Q4 25
$278.6M
$103.7M
Q3 25
$491.5M
$106.5M
Q2 25
$250.2M
$103.7M
Q1 25
$253.3M
$118.9M
Q4 24
$84.0M
$113.8M
Q3 24
$97.3M
$105.7M
Q2 24
$162.3M
$97.9M
Q1 24
$169.0M
$107.4M
Total Debt
CIM
CIM
INGN
INGN
Q4 25
$251.5M
Q3 25
$251.0M
Q2 25
$135.2M
Q1 25
$134.9M
Q4 24
$134.6M
Q3 24
$134.4M
Q2 24
$62.4M
Q1 24
Stockholders' Equity
CIM
CIM
INGN
INGN
Q4 25
$2.6B
$192.2M
Q3 25
$2.6B
$197.2M
Q2 25
$2.6B
$199.5M
Q1 25
$2.6B
$198.0M
Q4 24
$2.5B
$173.9M
Q3 24
$2.7B
$185.4M
Q2 24
$2.6B
$187.6M
Q1 24
$2.6B
$191.9M
Total Assets
CIM
CIM
INGN
INGN
Q4 25
$15.8B
$298.6M
Q3 25
$15.1B
$307.0M
Q2 25
$14.9B
$312.0M
Q1 25
$13.2B
$308.4M
Q4 24
$13.1B
$296.2M
Q3 24
$13.7B
$306.2M
Q2 24
$13.1B
$308.9M
Q1 24
$12.5B
$315.6M
Debt / Equity
CIM
CIM
INGN
INGN
Q4 25
0.10×
Q3 25
0.10×
Q2 25
0.05×
Q1 25
0.05×
Q4 24
0.05×
Q3 24
0.05×
Q2 24
0.02×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CIM
CIM
INGN
INGN
Operating Cash FlowLast quarter
$-248.9M
$-943.0K
Free Cash FlowOCF − Capex
$-1.9M
FCF MarginFCF / Revenue
-2.8%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
-8.78×
TTM Free Cash FlowTrailing 4 quarters
$-13.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CIM
CIM
INGN
INGN
Q4 25
$-248.9M
$-943.0K
Q3 25
$-137.5M
$2.2M
Q2 25
$-7.4M
$4.3M
Q1 25
$48.8M
$-16.8M
Q4 24
$205.7M
$-3.0M
Q3 24
$41.4M
$7.0M
Q2 24
$69.0M
$6.7M
Q1 24
$57.3M
$-4.7M
Free Cash Flow
CIM
CIM
INGN
INGN
Q4 25
$-1.9M
Q3 25
$1.6M
Q2 25
$3.7M
Q1 25
$-17.1M
Q4 24
$-3.3M
Q3 24
$5.3M
Q2 24
$6.6M
Q1 24
$-6.1M
FCF Margin
CIM
CIM
INGN
INGN
Q4 25
-2.8%
Q3 25
2.0%
Q2 25
4.6%
Q1 25
-24.9%
Q4 24
-5.0%
Q3 24
7.1%
Q2 24
8.9%
Q1 24
-9.6%
Capex Intensity
CIM
CIM
INGN
INGN
Q4 25
1.4%
Q3 25
0.7%
Q2 25
0.9%
Q1 25
0.4%
Q4 24
0.5%
Q3 24
2.2%
Q2 24
0.1%
Q1 24
2.1%
Cash Conversion
CIM
CIM
INGN
INGN
Q4 25
-8.78×
Q3 25
Q2 25
-0.21×
Q1 25
0.29×
Q4 24
Q3 24
0.30×
Q2 24
1.22×
Q1 24
0.44×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CIM
CIM

Segment breakdown not available.

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

Related Comparisons